e-book I Going to Market in an Autoinjector

- Vetter Advisory Board decides on strategic path forward for further independent and sustainable growth  

- Des Plaines, IL, and Saarlouis, Germany expansions add to an ongoing 1.5 billion Euro investment plan

- Vetter adds capacity within its core business of the clinical and commercial injectable filling of complex compounds

 

Our values make us as pharmaceutical service provider, employer, and family business unique. Find out what stands behind the Vetter name.

- Vetter defends Gold and Best in Class status
- CDMO impresses in all four evaluation categories

-  Outstanding example for combining economic success and leadership in sustainability

The rising demand for at-home self-administered therapies has made patient-friendly formats, such as autoinjectors, a necessity for drug manufacturers. However, the intricacies of manufacturing these devices pose significant challenges. This presentation offers valuable insights into planning the device assembly and packaging process, enabling drug owners to navigate this evolving landscape with confidence and efficiency.